Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Pediatría | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
RENIS
Estudio multicéntrico, abierto, para evaluar la farmacocinética, la seguridad y la eficacia de certolizumab pegol en niños y adolescentes con artritis idiopática juvenil activa, poliarticular de grado moderado a grave
INTERVENTIONAL
ID: IS000126
Completado
RENIS
Violencia de género en noviazgos adolescentes. Estudio cualitativo de tipo descriptivo de las representaciones sociales del amor y la violencia en adolescentes de dos escuelas públicas de la ciudad de Córdoba.
OBSERVATIONAL
ID: IS000106
Completado
RENIS
Encuesta global. Morbilidad materna severa
OBSERVATIONAL
ID: IS000098
Completado
RENIS
Las dificultades en los modos de vinculación entre adolescentes-jóvenes y Unidades Sanitarias, como obstáculos en la accesibilidad de la atención de la salud.
OBSERVATIONAL
ID: IS000056
Completado
RENIS
Enfermedadad Celiaca en Población Pediatrica de Riesgo Nutricional de Tucumán
OBSERVATIONAL
ID: IS000054
Completado
RENIS
Ensayo Clínico Aleatorizado, a Ciegas y Controlado con Placebo, de la Aplicacion Perilesional del CIGB-300 en Dos Niveles de Dosis en la Condilomatosis Genital Recidivante y No Recidivantes
INTERVENTIONAL
ID: IS000009
Completado
RENIS
Población Infanto-Juvenil alojada en Hogares Convivenciales, Terapéuticos y/o Maternales de la CABA, que ha transitado por un Programa de Atención Comunitaria para Niños/as y Adolescentes con Trastornos Mentales Severos durante el año 2010.
OBSERVATIONAL
ID: IS000005
Completado
Fase 3
ClinicalTrials.gov
An Open-label Trial of the Long-term Safety and Tolerability of Nintedanib Per os, on Top of Standard of Care, Over at Least 3 Years, in Children and Adolescents With Clinically Significant Fibrosing Interstitial Lung Disease (InPedILD®-ON)
INTERVENTIONAL
Inicio: 6 de abr de 2022
ID: NCT05285982
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Active-Controlled, Open-Label, Flexible-Dose Study to Assess the Safety and Tolerability of Topiramate as Monotherapy Compared With Levetiracetam as Monotherapy in Pediatric Subjects With New or Recent-Onset Epilepsy
INTERVENTIONAL
Inicio: 6 de oct de 2014
ID: NCT02201251
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Investigate the Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects With Epilepsy >=1 Month to <4 Years of Age With Partial-Onset Seizures
INTERVENTIONAL
Inicio: 5 de jun de 2015
ID: NCT02477839
Completado
Fase 1
ClinicalTrials.gov
A Phase I Pharmacokinetic and Safety Study of Tocilizumab (TCZ) in Patients Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis (sJIA)
INTERVENTIONAL
Inicio: 26 de oct de 2012
ID: NCT01455701
Completado
Fase 2
ClinicalTrials.gov
SIOP Study of Combined Modality Treatment in Childhood Ependymoma
INTERVENTIONAL
Inicio: 1 de ene de 1999
ID: NCT00004224
Reclutando
Fase 3
ClinicalTrials.gov
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled Trial to Assess the Effects of Oral TRPC6 Inhibitor BI 764198 Taken Over a 104 Week Treatment Period in Adult and Adolescent Participants With Primary Focal Segmental Glomerulosclerosis (pFSGS) or Genetic FSGS Related to TRPC6 Gene Variants
INTERVENTIONAL
Inicio: 16 de feb de 2026
ID: NCT07220083
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Parallel Group, Multicenter Study of Fluticasone Furoate/Vilanterol 200/25 mcg Inhalation Powder, Fluticasone Furoate/Vilanterol 100/25 mcg Inhalation Powder, and Fluticasone Furoate 100 mcg Inhalation Powder in the Treatment of Persistent Asthma in Adults and Adolescents
INTERVENTIONAL
Inicio: 20 de sept de 2012
ID: NCT01686633
Completado
Fase 2
ClinicalTrials.gov
A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 2-PART STUDY TO EVALUATE EDP-938 REGIMENS IN SUBJECTS AGED 28 DAYS TO 36 MONTHS INFECTED WITH RESPIRATORY SYNCYTIAL VIRUS (RSV)
INTERVENTIONAL
Inicio: 26 de abr de 2022
ID: NCT04816721
Terminado
Fase 3
ClinicalTrials.gov
Multinational, Randomized, Double Blind, Comparative Study to Evaluate the Efficacy and Safety of 5 Days Telithromycin 800 mg od Versus 10 Days Penicillin V 500 mg Tid in Adolescent and Adult Subjects Equal to or Over 13 Years With Streptococcus Pyogenes Tonsillitis/Pharyngitis
INTERVENTIONAL
Inicio: 1 de feb de 2006
ID: NCT00315549
Reclutando
Fase 3
ClinicalTrials.gov
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
INTERVENTIONAL
Inicio: 1 de abr de 2013
ID: NCT01949129
Completado
Fase 4
ClinicalTrials.gov
Study HZA114971, A Multicentre Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effects of a One-Year Regimen of Orally Inhaled Fluticasone Furoate 50 mcg Once Daily on Growth Velocity in Prepubertal, Paediatric Subjects With Asthma
INTERVENTIONAL
Inicio: 10 de jul de 2017
ID: NCT02889809
Desconocido
Fase 2
ClinicalTrials.gov
An Open-label, Multicenter Study in Male Pediatric Patients With Cerebral X-linked Adrenoleukodystrophy (Cald) to Assess the Effects of MIN-102 Treatment on Disease Progression Prior to Human Stem Cell Transplant (HSCT)
INTERVENTIONAL
Inicio: 13 de sept de 2019
ID: NCT04528706
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Double-dummy, Parallel Group, Multicenter Study of Once Daily Fluticasone Furoate/Vilanterol 100/25 mcg Inhalation Powder, Twice Daily Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and Twice Daily Fluticasone Propionate 250 mcg Inhalation Powder in the Treatment of Persistent Asthma in Adults and Adolescents Already Adequately Controlled on Twice-daily Inhaled Corticosteroid and Long-acting beta2 Agonist
INTERVENTIONAL
Inicio: 1 de mar de 2015
ID: NCT02301975
Anterior
1
...
12
13
14
...
434
Siguiente
Filtros